BlossomHill 制药 BLSM
$13.50 +$1.15 (+9.31%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $13.50 0.00%
开盘$12.29
昨收$12.35
当日区间$12.14 – $14.09
成交量174.3K
市值$429.10M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$24.67M-74.9% YoY
净利润-$23.76M-79.4% YoY
摊薄每股收益-$0.78-22.0% YoY
自由现金流-$23.23M-138.6% YoY
经营现金流-$23.23M
营收，近4个季度
净利润，近4个季度
各季度摊薄每股收益
各季度自由现金流
盈利能力与资产负债表
资产收益率-65.7%
流动比率5.42
负债/资产比率240.8%
现金及投资$95.38M
总负债$22.22M
净现金（净负债）$73.15M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| 研发费用 | $21.36M | $19.90M | $56.14M | $12.53M | $9.57M |
| -管理费用 | $3.32M | $2.21M | $7.89M | $1.57M | $1.88M |
| 其他收入（支出） | -$3,000.00 | -$3,000.00 | -$11,000.00 | – | – |
| 其他非经营性收入（支出） | -$3,000.00 | -$3,000.00 | -$11,000.00 | – | – |
| 税前利润 | -$23.76M | -$21.01M | -$60.56M | -$13.24M | -$10.48M |
| 净利润 | -$23.76M | -$21.01M | -$60.56M | -$13.24M | -$10.48M |
| 持续经营利润 | -$23.76M | -$21.01M | -$60.56M | -$13.24M | -$10.48M |
| 归属母公司净利润 | -$23.76M | -$21.01M | -$60.56M | -$13.24M | -$10.48M |
| 归属普通股股东净利润 | -$23.76M | -$21.01M | -$60.56M | -$13.24M | -$10.48M |
| 基本每股收益 | -$0.78 | -$1.01 | -$3.69 | -$0.64 | -$0.50 |
| 非经营性利息净收入（支出） | $915,000.00 | $1.10M | $3.48M | $859,000.00 | $976,000.00 |
| 营业利润 | -$24.67M | -$22.11M | -$64.02M | -$14.10M | -$11.45M |
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $24.67M | $22.11M | $64.02M | $14.10M | $11.45M |
| 销售及管理费用 | $3.32M | $2.21M | $7.89M | $1.57M | $1.88M |
| 摊薄每股收益 | -$0.78 | -$1.01 | -$3.69 | -$0.64 | -$0.50 |
| 非经营性利息收入 | $915,000.00 | $1.10M | $3.48M | $859,000.00 | $976,000.00 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2024 ANNUAL |
|---|---|---|---|---|
| 流动负债合计 | $18.62M | $16.18M | $15.48M | $6.77M |
| 应付款 | $3.93M | $5.38M | $2.31M | $849,000.00 |
| -应付账款 | $3.93M | $5.38M | $2.31M | $849,000.00 |
| 一年内应计费用 | $12.73M | $10.31M | $13.16M | $5.40M |
| 短期债务及融资租赁负债 | $1.15M | $493,000.00 | $5,000.00 | $525,000.00 |
| -一年内到期融资租赁负债 | $1.15M | $493,000.00 | $5,000.00 | $525,000.00 |
| 其他流动负债 | $809,000.00 | – | – | – |
| 非流动负债合计 | $280.29M | $279.35M | $279.22M | $172.89M |
| 长期债务及融资租赁负债 | $22.22M | $22.53M | $22.39M | $0.00 |
| 负债合计 | $298.91M | $295.53M | $294.70M | $179.66M |
| 总资产 | $124.13M | $143.41M | $162.97M | $106.78M |
| 流动资产合计 | $100.97M | $119.72M | $138.83M | $104.17M |
| 现金及现金等价物与短期投资 | $95.38M | $116.00M | $136.68M | $100.15M |
| -现金及现金等价物 | $95.38M | $116.00M | $136.68M | $100.15M |
| 其他流动资产 | $5.59M | $3.72M | $2.14M | $4.03M |
| 非流动资产合计 | $23.16M | $23.69M | $24.14M | $2.60M |
| 固定资产净值 | $20.69M | $21.21M | $21.56M | $1.50M |
| -固定资产原值 | $20.69M | $21.21M | $22.81M | $2.46M |
| -长期融资租赁负债 | $22.22M | $22.53M | $22.39M | $0.00 |
| 可转换优先证券 | $256.82M | $256.82M | $256.82M | $172.89M |
| 留存收益 | -$179.80M | -$156.04M | -$135.03M | -$74.47M |
| 其他非流动负债 | $1.25M | – | – | – |
| 股东权益合计 | -$174.78M | -$152.12M | -$131.73M | -$72.88M |
| 股东权益 | -$174.78M | -$152.12M | -$131.73M | -$72.88M |
| 股本 | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 |
| -普通股 | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 |
| 资本公积 | $5.01M | $3.92M | $3.30M | $1.59M |
| 其他非流动资产 | $2.48M | $2.48M | $2.50M | $1.02M |
| 商誉及其他无形资产 | – | – | $89,000.00 | $89,000.00 |
| -其他无形资产 | – | – | $89,000.00 | $89,000.00 |
| -累计折旧 | – | – | -$1.25M | -$959,000.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| 持续经营净利润 | -$23.76M | -$21.01M | -$60.56M | -$13.24M | -$10.48M |
| 折旧、折耗与摊销 | $125,000.00 | $125,000.00 | $441,000.00 | $102,000.00 | $85,000.00 |
| 其他非现金项目 | $399,000.00 | $325,000.00 | $1.29M | $303,000.00 | $179,000.00 |
| 营运资金变动 | -$577,000.00 | -$705,000.00 | $10.81M | $3.44M | -$996,000.00 |
| -预付资产变动 | -$1.22M | -$1.11M | $1.91M | $485,000.00 | $1.77M |
| -应付账款及应计费用变动 | $293,000.00 | -$241,000.00 | $9.23M | $2.64M | -$1.00M |
| -其他流动资产变动 | $0.00 | $18,000.00 | -$1.48M | $82,000.00 | -$1.57M |
| -其他流动负债变动 | $347,000.00 | $624,000.00 | $1.15M | $241,000.00 | -$193,000.00 |
| 持续经营投资活动现金流净额 | $0.00 | -$13,000.00 | -$1.07M | -$595,000.00 | -$402,000.00 |
| 固定资产购置及出售净额 | $0.00 | -$13,000.00 | -$1.07M | -$595,000.00 | -$402,000.00 |
| 筹资活动现金流 | $2.61M | $274,000.00 | $84.53M | $46,000.00 | $39,000.00 |
| 持续经营筹资活动现金流净额 | $2.61M | $274,000.00 | $84.53M | $46,000.00 | $39,000.00 |
| 股票期权行使所得 | $2.61M | $274,000.00 | $589,000.00 | $46,000.00 | $39,000.00 |
| 现金净变动 | -$20.63M | -$20.68M | $36.54M | -$9.69M | -$11.34M |
| 期初现金余额 | $116.00M | $136.68M | $100.15M | $88.81M | $100.15M |
| 持续经营经营活动现金流净额 | -$23.23M | -$20.94M | -$46.93M | -$9.14M | -$10.98M |
| 投资活动现金流净额 | $0.00 | -$13,000.00 | -$1.07M | -$595,000.00 | -$402,000.00 |
| 期末现金余额 | $95.38M | $116.00M | $136.68M | $79.11M | $88.81M |
| 自由现金流 | -$23.23M | -$20.95M | -$47.99M | -$9.74M | -$11.38M |
| 经营活动现金流 | -$23.23M | -$20.94M | -$46.93M | -$9.14M | -$10.98M |
| 优先股发行净额 | – | – | $83.94M | – | – |
暂无评论——快来第一个聊聊 BLSM。
登录后参与讨论。